NASDAQ:ATXS
Astria Therapeutics
- Stock
Last Close
11.77
08/11 21:00
Market Cap
572.19M
Beta: 0.92
Volume Today
136.51K
Avg: 227.03K
PE Ratio
−7.69
PFCF: −15.76
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||||||
average payables | 891.50K - | 1.23M 37.97% | 1.37M 11.10% | 1.09M 20.31% | 1.09M 0.14% | 1.30M 19.44% | 1.37M 5.22% | 1.55M 13.13% | 1.17M 24.38% | 1.15M 1.88% | ||
average receivables | ||||||||||||
book value per share | -361.33 - | -505.83 39.99% | 376.72 174.48% | 107.53 71.46% | 32.63 69.65% | 41.48 27.10% | 19.14 53.86% | 13.30 30.52% | 13.70 3.06% | 15.13 10.41% | ||
capex per share | -0.30 - | -1.58 430.23% | -3.14 98.96% | -1.70 45.98% | -0.16 90.70% | 0.02 113.55% | -0.01 130.09% | -0.01 67.82% | -0.00 78.19% | -0.01 164.53% | ||
capex to depreciation | -0.13 - | -0.92 584.17% | -2.08 126.70% | -1.16 44.24% | -0.19 83.86% | 0.15 180.67% | -0.46 405.13% | |||||
capex to operating cash flow | 0.00 - | 0.01 325.13% | 0.01 26.51% | 0.01 1.14% | 0.00 84.80% | -0.00 136.12% | 0.00 158.88% | 0.00 124.92% | 0.00 31.44% | 0.00 200.13% | 0.00 82.53% | |
capex to revenue | -0.11 - | |||||||||||
cash per share | 211.01 - | 101.56 51.87% | 468.40 361.19% | 142.43 69.59% | 45.30 68.20% | 44.59 1.55% | 19.42 56.46% | 14.69 24.35% | 14.06 4.27% | 15.49 10.14% | ||
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | ||||||||||||
debt to assets | 0.30 - | 0.14 53.16% | 0.14 2.15% | 0.14 2.66% | 0.05 - | 0.02 59.13% | 0.00 87.01% | 0.00 42.24% | 0.00 68.27% | |||
debt to equity | -0.06 - | 0.18 372.63% | 0.20 11.02% | 0.21 6.86% | 0.06 - | 0.03 59.22% | 0.00 88.40% | 0.00 42.24% | 0.00 68.12% | |||
dividend yield | 0.51 - | |||||||||||
earnings yield | -0.16 - | -0.19 20.79% | -0.51 163.38% | -0.62 20.28% | -0.85 37.63% | -1.17 38.26% | -0.40 66.14% | -0.94 138.03% | -0.63 33.54% | -0.23 63.26% | ||
enterprise value | 82.18M - | 102.73M 25.01% | 9.94M 90.32% | 40.72M 309.65% | 18.42M 54.77% | 6.80M 63.10% | 58.54M 761.45% | 15.39M 73.71% | -38.04M 347.18% | 198.12M 620.86% | -175.20M 188.43% | |
enterprise value over ebitda | -4.62 - | -4.79 3.83% | -0.31 93.45% | -1.17 272.29% | -0.69 40.78% | -0.26 61.74% | -2.23 741.24% | -0.41 81.56% | -0.28 31.08% | -3.70 1,207.02% | 2.11 156.99% | |
ev to operating cash flow | -5.02 - | -5.03 0.23% | -0.33 93.37% | -1.24 271.44% | -0.69 44.62% | -0.29 57.80% | -2.20 660.80% | -0.47 78.50% | 1.26 366.31% | -4.55 460.75% | 2.56 156.25% | |
ev to sales | 36.83 - | |||||||||||
free cash flow per share | -113.62 - | -142.91 25.78% | -225.42 57.73% | -123.17 45.36% | -74.42 39.58% | -27.83 62.60% | -14.24 48.83% | -10.63 25.34% | -3.38 68.20% | -2.98 11.74% | ||
free cash flow yield | -0.15 - | -0.18 25.78% | -0.47 158.58% | -0.57 20.02% | -0.83 46.40% | -1.06 27.51% | -0.40 62.16% | -0.83 106.18% | -0.63 24.25% | -0.20 68.05% | ||
graham net net | -364.99 - | -514.80 41.05% | 365.96 171.09% | 101.31 72.32% | 28.40 71.96% | 39.58 39.34% | 16.17 59.14% | 12.47 22.88% | 13.48 8.09% | 14.84 10.12% | ||
graham number | 1.01K - | 1.31K 30.03% | 1.44K 9.39% | 567.90 60.47% | 235.80 58.48% | 169.28 28.21% | 77.81 54.04% | 60.21 22.61% | 32.29 46.38% | 34.18 5.86% | ||
income quality | 0.90 - | 0.93 3.26% | 0.91 2.11% | 0.91 0.20% | 0.98 7.63% | 0.91 7.51% | 1.01 11.41% | 0.87 13.81% | 0.15 82.24% | 0.84 442.93% | 0.94 11.81% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -105.25 - | -32.37 69.24% | -42.48 31.24% | -58.65 38.04% | -263.71 349.67% | 32.06 - | ||||||
interest debt per share | 34.30 - | 74.05 115.87% | 24.25 67.26% | 8.14 66.43% | 0.12 98.54% | 1.21 916.92% | 0.34 71.67% | 0.04 88.04% | -0.05 222.09% | |||
inventory turnover | ||||||||||||
invested capital | -0.06 - | 0.18 372.63% | 0.20 11.02% | 0.21 6.86% | 0.06 - | 0.03 59.22% | 0.00 88.40% | 0.00 42.24% | 0.00 68.12% | |||
market cap | 112.65M - | 112.65M 0% | 63.77M 43.39% | 58.59M 8.12% | 32.31M 44.86% | 22.09M 31.62% | 66.19M 199.63% | 39.27M 40.66% | 48.11M 22.50% | 217.70M 352.54% | ||
net current asset value | -52.60M - | -74.00M 40.66% | 49.85M 167.37% | 28.41M 43.02% | 11.36M 60.01% | 34.69M 205.41% | 32.90M 5.16% | 39.54M 20.18% | 121.87M 208.24% | 217.02M 78.07% | 239.39M 10.31% | |
net debt to ebitda | 1.71 - | 0.46 72.96% | 1.70 267.42% | 0.51 69.83% | 0.52 1.76% | 0.60 14.17% | 0.29 51.18% | 0.64 119.18% | -0.64 200.57% | 0.37 157.05% | 2.11 476.41% | |
net income per share | -125.45 - | -151.53 20.79% | -243.45 60.66% | -133.31 45.24% | -75.73 43.19% | -30.71 59.45% | -14.06 54.21% | -12.12 13.81% | -3.38 72.10% | -3.43 1.49% | ||
operating cash flow per share | -113.32 - | -141.34 24.72% | -222.28 57.27% | -121.47 45.35% | -74.26 38.86% | -27.85 62.50% | -14.23 48.89% | -10.62 25.39% | -3.38 68.19% | -2.98 11.86% | ||
payables turnover | ||||||||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | 37.36 - | |||||||||||
return on tangible assets | -0.58 - | -1.37 134.57% | -0.51 62.94% | -0.90 76.51% | -1.53 70.49% | -0.66 56.80% | -0.63 4.90% | -0.78 24.34% | -0.24 69.70% | -0.22 8.08% | -0.29 31.59% | |
revenue per share | 1.38 - | |||||||||||
roe | 0.35 - | 0.30 13.72% | -0.65 315.72% | -1.24 91.85% | -2.32 87.18% | -0.74 68.10% | -0.73 0.77% | -0.91 24.05% | -0.25 72.93% | -0.23 8.08% | -0.30 32.21% | |
roic | 0.35 - | 0.32 7.71% | -0.55 270.20% | -1.05 92.13% | -1.93 84.45% | -0.77 60.05% | -0.67 12.97% | -0.87 29.43% | -0.25 71.80% | -0.23 5.38% | -0.34 46.75% | |
sales general and administrative to revenue | 17.82 - | |||||||||||
shareholders equity per share | -361.33 - | -505.83 39.99% | 376.72 174.48% | 107.53 71.46% | 32.63 69.65% | 41.48 27.10% | 19.14 53.86% | 13.30 30.52% | 13.70 3.06% | 15.13 10.41% | ||
stock based compensation to revenue | 4.01 - | |||||||||||
tangible asset value | -52.18M - | -73.05M 39.99% | 50.49M 169.12% | 29.09M 42.40% | 11.79M 59.46% | 34.94M 196.32% | 35.72M 2.23% | 40.67M 13.85% | 122.31M 200.75% | 221.22M 80.86% | 243.12M 9.90% | |
tangible book value per share | -361.33 - | -505.83 39.99% | 376.72 174.48% | 107.53 71.46% | 32.63 69.65% | 41.48 27.10% | 19.14 53.86% | 13.30 30.52% | 13.70 3.06% | 15.13 10.41% | ||
working capital | 27.65M - | 10.79M 60.99% | 55.77M 416.99% | 31.20M 44.05% | 11.45M 63.31% | 34.74M 203.52% | 33.93M 2.35% | 39.94M 17.71% | 121.87M 205.18% | 225.85M 85.32% | 239.39M 5.99% |
All numbers in USD (except ratios and percentages)